{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:19:25Z","timestamp":1780046365653,"version":"3.53.1"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1212\/con.0000000000000682","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T11:24:20Z","timestamp":1544009060000},"page":"1753-1775","source":"Crossref","is-referenced-by-count":8,"title":["Critical Care of Neuromuscular Disorders"],"prefix":"10.1212","volume":"24","author":[{"given":"Diana","family":"Greene-Chandos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Torbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-63600-3.00001-5","article-title":"The history of neurocritical care","volume":"140","author":"Wijdicks EF","year":"2017","unstructured":"Wijdicks EF. The history of neurocritical care. Handb Clin Neurol 2017;140:3\u201314. doi:10.1016\/B978-0-444-63600-3.00001-5.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12028-017-0450-3","article-title":"Emergency neurological life support: acute non-traumatic weakness","volume":"27","author":"Caulfield AF","year":"2017","unstructured":"Caulfield AF Flower O Pineda JA Uddin S. Emergency neurological life support: acute non-traumatic weakness. Neurocrit Care 2017;27(suppl 1):29\u201350. doi:10.1007\/s12028-017-0450-3.","journal-title":"Neurocrit Care"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<610::AID-MUS7>3.0.CO;2-B"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000239436.63452.81"},{"issue":"10","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1097\/CCM.0b013e3181b6ef67","article-title":"A framework for diagnosing and classifying intensive care unit-acquired weakness","volume":"37","author":"Stevens RD","year":"2009","unstructured":"Stevens RD Marshall SA Cornblath DR. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37(10 suppl):S299\u2013S308. doi:10.1097\/CCM.0b013e3181b6ef67.","journal-title":"Crit Care Med"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/B978-0-444-63599-0.00029-6","article-title":"Intensive care unit-acquired weakness","volume":"141","author":"Horn J","year":"2017","unstructured":"Horn J Hermans G. Intensive care unit-acquired weakness. Handb Clin Neurol 2017;141:531\u2013543. doi:10.1016\/B978-0-444-63599-0.00029-6.","journal-title":"Handb Clin Neurol"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70178-8"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200712-1829OC"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23615"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3979-7"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60658-9"},{"issue":"2","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/cc7728","article-title":"Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms","volume":"13","author":"Callahan LA","year":"2009","unstructured":"Callahan LA Supinski GS. Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms. Crit Care 2009;13(2):125. doi:10.1186\/cc7728.","journal-title":"Crit Care"},{"issue":"1","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/cc7694","article-title":"Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study","volume":"13","author":"Hermans G","year":"2009","unstructured":"Hermans G Schrooten M Van Damme P. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care 2009;13(1):R5. doi:10.1186\/cc7694.","journal-title":"Crit Care"},{"issue":"19","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe G","year":"2001","unstructured":"van den Berghe G Wouters P Weekers F. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345(19):1359\u20131367. doi:10.1056\/NEJMoa011300.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052521"},{"issue":"10","key":"e_1_3_1_17_2","first-page":"616","article-title":"Euglycemic state reduces the incidence of critical illness polyneuropathy and duration of ventilator dependency in medical intensive care unit","volume":"113","author":"Mikaeili H","year":"2012","unstructured":"Mikaeili H Yazdchi M Barazandeh F Ansarin K. Euglycemic state reduces the incidence of critical illness polyneuropathy and duration of ventilator dependency in medical intensive care unit. Bratisl Lek Listy 2012;113(10):616\u2013619.","journal-title":"Bratisl Lek Listy"},{"issue":"5","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/cc13028","article-title":"Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and\/or myopathy in patients with multiple organ failure and SIRS\/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial","volume":"17","author":"Brunner R","year":"2013","unstructured":"Brunner R Rinner W Haberler C. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and\/or myopathy in patients with multiple organ failure and SIRS\/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial. Crit Care 2013;17(5):R213. doi:10.1186\/cc13028.","journal-title":"Crit Care"},{"issue":"5","key":"e_1_3_1_19_2","first-page":"907","article-title":"Rhabdomyolysis","volume":"65","author":"Sauret JM","year":"2002","unstructured":"Sauret JM Marinides G Wang GK. Rhabdomyolysis. Am Fam Physician 2002;65(5):907\u2013912.","journal-title":"Am Fam Physician"},{"issue":"1","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch X","year":"2009","unstructured":"Bosch X Poch E Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009;361(1):62\u201372. doi:10.1056\/NEJMra0801327.","journal-title":"N Engl J Med"},{"issue":"4","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jramc-149-04-02","article-title":"Consensus statement on the early management of crush injury and prevention of crush syndrome","volume":"149","author":"Greaves I","year":"2003","unstructured":"Greaves I Porter K Smith JE. Consensus statement on the early management of crush injury and prevention of crush syndrome. J R Army Med Corps 2003;149(4):255\u2013259.","journal-title":"J R Army Med Corps"},{"issue":"5","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/01.CON.0000455873.30438.9b","article-title":"Myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"20","author":"Sanders DB","year":"2014","unstructured":"Sanders DB Guptill JT. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Continuum (Minneap Minn) 2014;20(5 Peripheral Nervous System Disorders):1413\u20131425. doi:10.1212\/01.CON.0000455873.30438.9b.","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0032-1329200","article-title":"Myasthenia gravis","volume":"32","author":"Silvestri NJ","year":"2012","unstructured":"Silvestri NJ Wolfe GI. Myasthenia gravis. Semin Neurol 2012;32(3):215\u2013226. doi:10.1055\/s-0032-1329200.","journal-title":"Semin Neurol"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-444-63600-3.00013-1","article-title":"Management of acute neuromuscular disorders","volume":"140","author":"Wijdicks EF","year":"2017","unstructured":"Wijdicks EF. Management of acute neuromuscular disorders. Handb Clin Neurol 2017;140:229\u2013237. doi:10.1016\/B978-0-444-63600-3.00013-1.","journal-title":"Handb Clin Neurol"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000212371","article-title":"Myasthenia gravis with anti-acetylcholine receptor antibodies","volume":"26","author":"Meriggioli MN","year":"2009","unstructured":"Meriggioli MN. Myasthenia gravis with anti-acetylcholine receptor antibodies. Front Neurol Neurosci 2009;26:94\u2013108. doi:10.1159\/000212371.","journal-title":"Front Neurol Neurosci"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(02)00137-2"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.5.1253"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170207"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.437"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22139"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000033797.79530.16"},{"issue":"1","key":"e_1_3_1_33_2","article-title":"Emergency neurological life support: acute non-traumatic weakness","volume":"17","author":"Flower O","year":"2012","unstructured":"Flower O Bowles C Wijdicks E. Emergency neurological life support: acute non-traumatic weakness. Neurocrit Care 2012;17(suppl 1):S79\u2013S95. doi:10.1007\/s12028-012-9752-7.","journal-title":"Neurocrit Care"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1659-y"},{"issue":"7","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.65.7.929","article-title":"Predictors of extubation failure in myasthenic crisis","volume":"65","author":"Seneviratne J","year":"2008","unstructured":"Seneviratne J Mandrekar J Wijdicks EF Rabinstein AA. Predictors of extubation failure in myasthenic crisis. Arch Neurol 2008;65(7):929\u2013933. doi:10.1001\/archneur.65.7.929.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22006"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03019.x"},{"key":"e_1_3_1_38_2","first-page":"CD002277","article-title":"Intravenous immunoglobulin for myasthenia gravis","volume":"12","author":"Gajdos P","year":"2012","unstructured":"Gajdos P Chevret S Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 2012;12:CD002277. doi:10.1002\/14651858.CD002277.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e5505"},{"issue":"11","key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archneur.62.11.1689","article-title":"Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial","volume":"62","author":"Gajdos P","year":"2005","unstructured":"Gajdos P Tranchant C Clair B. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial. Arch Neurol 2005;62(11):1689\u20131693. doi:10.1001\/archneur.62.11.1689.","journal-title":"Arch Neurol"},{"issue":"2","key":"e_1_3_1_41_2","first-page":"CD002828","article-title":"Corticosteroids for myasthenia gravis","author":"Schneider-Gold C","year":"2005","unstructured":"Schneider-Gold C Gajdos P Toyka KV Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005;(2):CD002828. doi:10.1002\/14651858.CD002828.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1778"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23412"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.705831"},{"issue":"1","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth GS","year":"2000","unstructured":"Gronseth GS Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55(1):7\u201315. doi:10.1212\/WNL.55.1.7.","journal-title":"Neurology"},{"issue":"4","key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","article-title":"Treatment of MuSK-associated myasthenia gravis","volume":"16","author":"El-Salem K","year":"2014","unstructured":"El-Salem K Yassin A Al-Hayk K. Treatment of MuSK-associated myasthenia gravis. Curr Treat Options Neurol 2014;16(4):283. doi:10.1007\/s11940-014-0283-8.","journal-title":"Curr Treat Options Neurol"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70245-9"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8541-9"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(02)00054-9"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506013322203"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1637-4"},{"issue":"29","key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.15585\/mmwr.mm6429a6","article-title":"Large outbreak of botulism associated with a church potluck meal\u2013Ohio, 2015","volume":"64","author":"McCarty CL","year":"2015","unstructured":"McCarty CL Angelo K Beer KD. Large outbreak of botulism associated with a church potluck meal\u2013Ohio, 2015. MMWR Morb Mortal Wkly Rep 2015;64(29):802\u2013803.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMra1409755","article-title":"Clinical management of potential bioterrorism-related conditions","volume":"372","author":"Adalja AA","year":"2015","unstructured":"Adalja AA Toner E Inglesby TV. Clinical management of potential bioterrorism-related conditions. N Engl J Med 2015;372(10):954\u2013962. doi:10.1056\/NEJMra1409755.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.172"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.002"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v5.i4.135"},{"key":"e_1_3_1_59_2","first-page":"496","article-title":"Zika virus: the latest newcomer","volume":"7","author":"Saiz JC","year":"2016","unstructured":"Saiz JC V\u00e1zquez-Calvo \u00c1 Bl\u00e1zquez AB. Zika virus: the latest newcomer. Front Microbiol 2016;7:496. doi:10.3389\/fmicb.2016.00496.","journal-title":"Front Microbiol"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707"},{"issue":"6","key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Lawn ND","year":"2001","unstructured":"Lawn ND Fletcher DD Henderson RD. Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome. Arch Neurol 2001;58(6):893\u2013898. doi:10.1001\/archneur.58.6.893.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-016-0311-5"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(05)70293-1"},{"issue":"1","key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc10043","article-title":"A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome","volume":"15","author":"Fourrier F","year":"2011","unstructured":"Fourrier F Robriquet L Hurtevent JF Spagnolo S. A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome. Crit Care 2011;15(1):R65. doi:10.1186\/cc10043.","journal-title":"Crit Care"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<613::AID-MUS21>3.0.CO;2-4"},{"issue":"257","key":"e_1_3_1_66_2","first-page":"735","article-title":"Identification of patients at risk of arrhythmia in the Guillain-Barr\u00e9 syndrome","volume":"68","author":"Winer JB","year":"1988","unstructured":"Winer JB Hughes RA. Identification of patients at risk of arrhythmia in the Guillain-Barr\u00e9 syndrome. Q J Med 1988;68(257):735\u2013739. doi:10.1093\/oxfordjournals.qjmed.a068239.","journal-title":"Q J Med"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/0148607192016005464"},{"key":"e_1_3_1_68_2","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Rapha\u00ebl JC","year":"2017","unstructured":"Rapha\u00ebl JC Chevret S Hughes RA Annane D. Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev 2017;2:CD001798. doi:10.1002\/14651858.CD001798.","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Bar\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9 FG","year":"1992","unstructured":"van der Mech\u00e9 FG Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Bar\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group. N Engl J Med 1992;326(17):1123\u20131129. doi:10.1056\/NEJM199204233261705.","journal-title":"N Engl J Med"},{"issue":"9047","key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"349","author":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","year":"1997","unstructured":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Lancet 1997;349(9047):225\u2013230. doi:10.1016\/S0140-6736(96)09095-2.","journal-title":"Lancet"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15324-X"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2311"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230406"},{"issue":"8","key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"The Guillain-Barr\u00e9 syndrome study group","volume":"35","author":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome","year":"1985","unstructured":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 syndrome study group. Neurology 1985;35(8):1096\u20131104.","journal-title":"Neurology"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.42"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1603471"},{"issue":"2","key":"e_1_3_1_77_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chi\u00f2 A","year":"2013","unstructured":"Chi\u00f2 A Logroscino G Traynor BJ. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41(2):118\u2013130. doi:10.1159\/000351153.","journal-title":"Neuroepidemiology"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1983.tb04810.x"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61156-7"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/118.3.707"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.4.455"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bc0141"},{"key":"e_1_3_1_83_2","unstructured":"US Food and Drug Administration. FDA approves drug to treat ALS. fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm557102.htm. Published May 5 2017. Accessed October 18 2018."},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1080\/17482960802430773"},{"issue":"3","key":"e_1_3_1_85_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","article-title":"EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2013revised report of an EFNS task force","volume":"19","author":"EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis","year":"2012","unstructured":"EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM Abrahams S. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2013revised report of an EFNS task force. Eur J Neurol 2012;19(3):360\u2013375. doi:10.1111\/j.1468-1331.2011.03501.x.","journal-title":"Eur J Neurol"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000250444.30622.ee"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00617-7"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.2.436"},{"issue":"5","key":"e_1_3_1_89_2","first-page":"575","article-title":"Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival [in French]","volume":"158","author":"Velasco R","year":"2002","unstructured":"Velasco R Salachas F Munerati E. Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival [in French]. Rev Neurol (Paris) 2002;158(5 pt 1):575\u2013578.","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"e_1_3_1_90_2","first-page":"CD004427","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","author":"Radunovic A","year":"2013","unstructured":"Radunovic A Annane D Rafiq MK Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev 2013;(3):CD004427. doi:10.1002\/14651858.CD004427.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70326-4"},{"issue":"11","key":"e_1_3_1_92_2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/thx.2011.160481","article-title":"Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival","volume":"66","author":"Sancho J","year":"2011","unstructured":"Sancho J Servera E D\u00edaz JL. Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival. Thorax 2011;66(11):948\u2013952. doi:10.1136\/thx.2011.160481.","journal-title":"Thorax"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2011.06.004"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60222-1"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2016.1259028"},{"issue":"7","key":"e_1_3_1_96_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(15)00104-0","article-title":"Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study","volume":"14","author":"ProGas Study Group","year":"2015","unstructured":"ProGas Study Group. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol 2015;14(7):702\u2013729. doi:10.1016\/S1474-4422(15)00104-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"e_1_3_1_97_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-2008-1041253","article-title":"Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations","volume":"10","author":"Gutmann L","year":"1990","unstructured":"Gutmann L Besser R. Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations. Semin Neurol 1990;10(1):46\u201351. doi:10.1055\/s-2008-1041253.","journal-title":"Semin Neurol"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201812000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:06:14Z","timestamp":1752156374000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1212\/CON.0000000000000682"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000682","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}